Psilocybin for quitting methamphetamine
Treatments studied
Part of Mental health clinical trials.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 65 years old.
- Methamphetamine is your main drug of choice and you want to stop using it completely.
- You have been in treatment at a local facility for at least 7 days.
- You can speak English and do not have other serious addictions (except nicotine or cannabis).
- You are willing to attend several therapy sessions, including telehealth calls and in-person visits.
- You have no major health problems like heart disease, uncontrolled high blood pressure, or a history of seizures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a psychedelic drug called psilocybin can help people cut down or stop using methamphetamine. You'll take the drug in a supervised setting and get support to aim for full abstinence.
This study tests whether a drug called psilocybin (a psychedelic) can help people with HIV stop using methamphetamine. If you want to quit meth and are living with HIV, this trial might offer a new approach.
This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This study tests whether combining a non-invasive brain stimulation technique (TMS) with a mental exercise called 'episodic future thinking' can help people reduce methamphetamine use. TMS uses magnetic pulses to stimulate brain areas linked to addiction, and episodic future thinking involves imagining positive future events to reduce cravings.
This trial tests whether a single dose of psilocybin (PEX010) combined with therapy can help people stop using methamphetamine or other stimulants. It focuses on safety and early signs of effectiveness.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.